Jazz Pharmaceuticals plc – Filings and Transcripts

NASDAQ: JAZZ
Share price (4/2/26): $186.95
Market cap (4/2/26): $11.5 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024 – amended

Prospectuses and Registrations Filter

Third party tender offer – amended

Third party tender offer – amended

Third party tender offer – amended

Third party tender offer – amended

Third party tender offer – amended

Ownership Filter

Vanguard Group Inc

Johnson Philip L

Henderson Mary Elizabeth

News Filter

Announces Full Year and Fourth Quarter 2025 Financial Results and Provides 2026 Financial Guidance

Investor Presentation

Ziihera Plus the PD-1 Inhibitor Tevimbra® (Tislelizumab) and Chemotherapy Demonstrated Clinically Meaningful and Statistically Significant Improvements in OS and PFS Versus Trastuzumab and Chemotherapy

Announces Third Quarter 2025 Financial Results and Updates 2025 Financial Guidance

Change in Directors, Officers or Compensation

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission

Correspondence with the SEC